NFKB1 and metabolic dysfunction-associated steatotic liver disease: Activation of NF-κB increases the production of proinflammatory cytokines (such as tumor necrosis factor α, interleukins 1 and 6), which has been linked with liver injury in the animal models of both NAFLD and ALD [46,47].